Cytokines in Cancer Immunotherapy

Cited by (504)

Items 301–400 of 504

1. Tackling HLA Deficiencies Head on with Oncolytic Viruses
   Kerry D. Fisher, Ahmet Hazini, Leonard William Seymour · 2021 · Cancers
2. Progesterone prevents HGSOC by promoting precancerous cell pyroptosis via inducing fibroblast paracrine
   Nayiyuan Wu, Xiaoye Zhang, Zhibin Wang, Xiu Zhang, Chao Fang, He Li, Miaochen Zhu, Ying Wang, Qianjin Liao, Tang‐Yuan Chu et al. · 2023 · iScience
3. Pilot Acute Safety Evaluation of Innocell™ Cancer Immunotherapy in Canine Subjects
   Raymond P. Goodrich, Jon Weston, Lindsay Hartson, Lynn R. Griffin, Amanda Guth · 2020 · Journal of Immunology Research
4. Endogenous and exogenous cytokines: An overview and introduction
   Thomas R. Spitzer, Hillard Michael Lazarus · 2025 · Best Practice & Research Clinical Haematology
5. Subtypes of tumor-associated neutrophils and their roles in cancer immunotherapy
   Xinyun Chu, Ning Pu, Xue Yang, Yuqi Xie, Liang Liu, Yun Jin · 2025 · Critical Reviews in Oncology/Hematology
6. Advances of oncolytic vaccinia viruses armed with interleukin in tumor therapy
   Mingyong Zha, Fei Huang, Song‐Lin Li, Qi Wang, Yong Tang · 2025 · Frontiers in Oncology
7. Role of interleukins in acute myeloid leukemia
   Yin Wang, Xiao Jun Tang, Yu Zhu, Xiaoxiao Yang, Bei Liu · 2023 · Leukemia & lymphoma/Leukemia and lymphoma
8. A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers
   Richard T. Kenney, John K. Cini, Susan Dexter, Manuel DaFonseca, Justus Bingham, Isabelle Kuan, Sant P. Chawla, Thomas M. Polasek, Jason D. Lickliter, Philip J. Ryan · 2024 · Frontiers in Immunology
9. Quantification and characterization of granulocyte macrophage colony-stimulating factor activated human peripheral blood mononuclear cells by fluorine-19 cellular MRI in an immunocompromised mouse model
   Corby Fink, Michael H. Smith, Olivia C. Sehl, Jeffrey M. Gaudet, Thomas Craig Meagher, Nadeem Anwar Sheikh, Jimmy Dimitrios Dikeakos, Michael John Rieder, Paula J. Foster, Gregory A. Dekaban · 2020 · Diagnostic and Interventional Imaging
10. Administration of fusion cytokines induces tumor regression and systemic antitumor immunity
    Jinyu Zhang, Xuan Zhao · 2021 · MedComm
11. Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article
    Rangarirai Makuku, Homa Seyedmirzaei, Marcarious Moorkereh Tantuoyir, Eduardo Rodríguez‐Román, Assil Albahash, Kawthar Mohamed, Ernest Moyo, Abdulrazaq Olamilekan Ahmed, Sepideh Razi, Nima Rezaei · 2022 · International Immunopharmacology
12. An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties
    Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiß, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri et al. · 2023 · Pharmaceutics
13. Pancreatic stellate cells and the interleukin family: Linking fibrosis and immunity to pancreatic ductal adenocarcinoma (Review)
    Haichao Li, Donglian Liu, Kaishu Li, Yichen Wang, Gengqiang Zhang, Ling Qi, Keping Xie · 2024 · Molecular Medicine Reports
14. Heterogeneity of tumor-associated neutrophils in hepatocellular carcinoma
    Fan Guixiang, Jintong Na, Zhen Shen, Faquan Lin, Liping Zhong · 2024 · Molecular Immunology
15. Nanobodies in cytokine‑mediated immunotherapy and immunoimaging (Review)
    Xiaochen Zhang, Jin Wang, Ying Tan, Chao-Ting Chen, Shuang Tang, Shimei Zhao, Qiuhong Qin, Hansheng Huang, Siliang Duan · 2023 · International Journal of Molecular Medicine
16. Exploring the detailed role of interleukins in cancer: A comprehensive review of literature
    Raed Obaid Saleh, Saade Abdalkareem Jasim, Wesam Radhi Kadhum, Ahmed M. Hjazi, Ali Faraz, Mohammed Kadhem Abid, Alexey Yumashev, Ahmed Hussien Alawadi, Ibrahim Ahmed Zaki Aiad, Ali Alsalamy · 2024 · Pathology - Research and Practice
17. Mechanistic and Structural Insights on the IL-15 System through Molecular Dynamics Simulations
    Rui P. Sousa, Adèle D. Laurent, Agnès Quéméner, Erwan Mortier, Jean‐Yves Le Questel · 2019 · Molecules
18. Evolution of γ chain cytokines: Mechanisms, methods and applications
    Magdalena Antczak, Pablo F. Cañete, Zhian Chen, Clemence J. Belle, Di Yu · 2022 · Computational and Structural Biotechnology Journal
19. Targeted chain-exchange-mediated reconstitution of a split type-I cytokine for conditional immunotherapy
    Vedran Vasic, Can M. Buldun, Manfred Ritz, Steffen Dickopf, Guy J. Georges, Christian Spick, Alessa Peuker, Thomas Meier, Klaus Mayer, Ulrich Brinkmann · 2023 · mAbs
20. Combination of ketogenic diet and probiotics inhibits breast cancer in mice by immune system modulation and reduction of Insulin growth factor-1
    Ayah Kamal, Wamidh H. Talib · 2023 · Pharmacia
21. Purification, Characterization and Immunomodulatory Activities of Polysaccharides fromMulberryLeaf Fermented withPhellinus igniarius
    Junfeng Li, Zhuoyan Zhou, Lisheng Chu, Xiawei Jiang, Jiabao Xu, Lichao Wu, Tingting Zhang, Jin Wang, Guilin Ren, Xin Mou et al. · 2021 · Journal of Biobased Materials and Bioenergy
22. The Assessment of IL-21 and IL-22 at the mRNA Level in Tumor Tissue and Protein Concentration in Serum and Peritoneal Fluid in Patients with Ovarian Cancer
    Aleksandra Mielczarek‐Palacz, Celina Kruszniewska‐Rajs, Marta Smycz‐Kubańska, Jarosław Strzelczyk, Wojciech Szanecki, Andrzej Witek, Joanna Magdalena Gola · 2021 · Journal of Clinical Medicine
23. Higher cytotoxic activities of CD8+ T cells and natural killer cells from peripheral blood of early diagnosed lung cancer patients
    Mohamed Labib Salem, Ismail Atia, Nehal Mohamed Elmashad · 2023 · BMC Immunology
24. Cytokine Therapeutics in Cancer Immunotherapy: Design and Development
    Juha Punnonen, David Brian Rosen, Luis Alejandro Zuniga, Kennett Sprogøe, Mohammad A. Tabrizi · 2019 · Current Pharmacology Reports
25. Comprehensive evaluation of breast cancer immunotherapy and tumor microenvironment characterization based on interleukin genes-related risk model
    Yalei Lv, Zihe Bai, Xiaoyan Wang, Jiayin Liu, Yuntao Li, Xiaolin Zhang, Yujie Shan · 2022 · Scientific Reports
26. Combination Therapy Approaches to Enhance the Efficacy of ERV-Targeting Vaccines in Cancer
    Maria Gracia-Hernandez, María del Mar Maldonado, Jeffrey Schlom, Duane H. Hamilton · 2025 · Cancer Immunology Research
27. Engineering mesoporous silica nanoparticles for cancer immunotherapy: mechanistic insights, therapeutic synergies, and translational roadmap
    Adel Mahmoudi Gharehbaba, Fatemeh Soltanmohammadi, Morteza Eskandani, Khosro Adibkia · 2026 · Materials & Design
28. Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments
    Amir Saamaan Fattahi, Mahboobeh Jafari, Ghazal Farahavar, Samira Sadat Abolmaali, Ali Mohammad Tamaddon · 2024 · Critical Reviews in Oncology/Hematology
29. Engineered CD4 T cells for in vivo delivery of therapeutic proteins
    Harikrishnan Radhakrishnan, Sherri L. Newmyer, Harold S. Javitz, Parijat Bhatnagar · 2024 · Proceedings of the National Academy of Sciences
30. Oncolytic vaccinia virus expressing non-secreted decoy-resistant IL-18 mutein elicits potent antitumor effects with enhanced safety
    Junjie Ye, Lingjuan Chen, Sefali Patel, Pingpo Ming, Chunyan Li, Julia Waltermire, Jinshun Zhao, Jinghua Ren, David L. Bartlett, Zuqiang Liu · 2025 · Molecular Therapy Oncology
31. Combinational immunotherapy based on immune checkpoints inhibitors in small cell lung cancer: is this the beginning to reverse the refractory situation?
    Haoyue Guo, Yayi He, Peixin Chen, Lei Wang, Wei Li, Bin Chen, Yu Liu, Hao Wang, Sha Zhao, Caicun Zhou · 2020 · Journal of Thoracic Disease
32. Expression of Interleukin-21 and Interleukin-21 receptor in lymphocytes derived from tumor-draining lymph nodes of breast cancer
    Sima Balouchi-Anaraki, Sara Mohammadsadeghi, Marzieh Norouzian, Reza Rasolmali, Abdolrasoul Talei, Fereshteh Mehdipour, Abbas Ali Ghaderi · 2022 · Breast Disease
33. How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles
    Yan Fu, Chu Hui Zeng, Chao An, Yue Liu, Ji Hoon Shin, Xiao Li · 2023 · Cancers
34. Strategies for cancer therapy
    Abeer Hamed Abdel-Halim · 2023 · Egyptian Pharmaceutical Journal
35. Role of macrophage polarization in cancer progression and their association with COVID-19 severity
    Abhimanyu Thakur, Rumpa Banerjee, Sudha Thakur, Gaurav Kumar, Shyam Sundar Thakur · 2023 · Cancer Insight
36. Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment
    Bárbara Carreira, Rita C. Acúrcio, Ana I. Matos, Carina Peres, Sabina Pozzi, Daniella Vaskovich‐Koubi, Ron Kleiner, Mariana Bento, Ronit Satchi‐Fainaro, Helena F. Florindo · 2020 · Advanced Therapeutics
37. Cancer Immunotherapy in Adult Patients with HIV
    Suha Abu Khalaf, Dima Dandachi, Bruno Palma Granwehr, Maria C. Rodriguez‐Barradas · 2022 · Journal of Investigative Medicine
38. Adipose tissue-derived extracellular vesicles from obese mice suppressed splenocyte-mediated pancreatic cancer cell death
    Inae Jeong, Shinjung Park, Jinbum Park, Ok‐Kyung Kim · 2024 · Food & Nutrition Research
39. Distinct peripheral pro‐inflammatory profile associated with tuberous sclerosis complex and epilepsy
    Renaud Balthazard, Rose‐Marie Drouin‐Engler, Samuel Bertrand, Fayçal Zine-Eddine, Jimmy Li, Olivier Tastet, Audrey Daigneault, Victoria Hannah Mamane, Gloria-Gabrielle Ortega-Delgado, Alina Maria Sreng Flores et al. · 2025 · Epilepsia
40. Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial
    Jenny Bulgarelli, Claudia Piccinini, Emanuela Scarpi, Giorgia Gentili, Laura Renzi, Silvia Carloni, Francesco Limarzi, Elena Pancisi, Anna Maria Granato, Massimiliano Petrini et al. · 2025 · Journal of Translational Medicine
41. Research Progress of Nanomaterials Acting on NK Cells in Tumor Immunotherapy and Imaging
    Yachan Feng, Haojie Zhang, Jiangtao Shao, Chao Du, Xiaolei Zhou, Xueling Guo, Yingze Wang · 2024 · Biology
42. Characterization of CPH : SA microparticle‐based delivery of interleukin‐1 alpha for cancer immunotherapy
    M.M. Hasibuzzaman, Rui He, Ishrat Nourin Khan, Rasna Sabharwal, Aliasger K. Salem, Andrean Llewela Simons‐Burnett · 2022 · Bioengineering & Translational Medicine
43. Immune Pathways with Aging Characteristics Improve Immunotherapy Benefits and Drug Prediction in Human Cancer
    Xinyue Wang, Shuang Guo, Hanxiao Zhou, Yue Sun, Jing Gan, Yakun Zhang, Wen Zheng, Caiyu Zhang, Xiaoxi Zhao, Jiebin Xiao et al. · 2023 · Cancers
44. Augmenting T-cell responses to tumors by in situ nanomanufacturing
    Mohammad Mahdi Hasani‐Sadrabadi, Fatemeh Sadat Majedi, Matthew Lee Miller, Timothy J. Thauland, Louis‐S. Bouchard, Song Li, Manish J. Butte · 2020 · Materials Horizons
45. In vitro evaluation of immunobiological activity of simple mannolipids
    Ema Paulovičová, Lucia Paulovičová, Monika Poláková, Miroslav Pánik, Soňa Jantová · 2020 · Toxicology in Vitro
46. Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer
    Seyer Safi, Yoshikane Yamauchi, Hans Hoffmann, Wilko Weichert, Philipp Jakob Jost, Hauke Winter, Thomas Muley, Philipp Beckhove · 2020 · Cancers
47. Construction and Evaluation of Clinical Prediction Model for Immunotherapy-related Adverse Events and Clinical Benefit in Cancer Patients Receiving Immune Checkpoint Inhibitors Based on Serum Cytokine Levels
    Ni Zhao, Aimin Jiang, Xiao Shang, Fumei Zhao, Ruoxuan Wang, Xiao Fu, Zhiping Ruan, Xuan Liang, Tao Tian, Yu Yao et al. · 2023 · Journal of Immunotherapy
48. Anti-PD-1 synergizes with RFA to suppress abscopal tumors and induce durable memory against recurrence in HCC
    Kai Lei, Shuang Li, Jiale Chen, Zebin Chen, Fang Wang, Xuezhen Zeng · 2025 · Liver Research
49. Immunotherapy-associated Cardiotoxicity: a Comprehensive Review of Checkpoint inhibitors, monoclonal, cellular, and cytokine-based Treatments
    Kalliopi Keramida, Theodora-Christina Kyriakou, Athos Antoniades, Carlo Gabriele Tocchetti · 2025 · Current Treatment Options in Oncology
50. Immunocytokines in cancer immunotherapy: opportunities and challenges
    Shubo Wang, Lisha Yao, Jianying Cai, Huiquan Gao, Fuxin Zhou · 2026 · Frontiers in Oncology
51. Circular RNAs in cancer: Its biogenesis, functions, relationships with cancer progression, applications in immunotherapy and biomarker potentials
    Yusen Gao, Lingling Xu, Ruihua Sun, Luping Gao, 颜培宇, Xinrong Yang, Guoliang Wang, Yanfang Xian, Jiewen Zhang, Di Zhu · 2026 · Cancer Immunology Immunotherapy
52. High expression of RNF31 is associated with tumor immune cell infiltration and leads to poor prognosis in liver hepatocellular carcinoma
    Guifu Xi, Run-Fen Cheng, Leiting Liang, Na Che, Yalei Wang, Nan Zhao, Xiaohui Liang, Bing Shao, Xiulan Zhao, Danfang Zhang · 2023 · Scientific Reports
53. Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapy
    Mika Casey, Carol Lee, Sharon M. Hoyte, Rebecca L. Johnston, Wing Yu Kwok, Soi Cheng Law, Maher K. Gandhi, Simon James Harrison, Kyohei Nakamura · 2024 · Haematologica
54. SQLE is a promising prognostic and immunological biomarker and correlated with immune Infiltration in Sarcoma
    Mengwei Shao, Ming‐Bo Wang, Xiliang Wang, Xiaodong Feng, L Y Zhang, Huicheng Lv · 2024 · Medicine
55. Mannose-modified erythrocyte membrane-coated Chuanmingshen violaceum polysaccharide PLGA nanoparticles to improve immune responses in mice
    Shuyao Yang, Xinnan Zhang, Yao Wang, Jie Liu, Lu Wang, Yi Liao, Yanwen Yang, Tao Dai, Xuemei Yin, Shanshan Li et al. · 2025 · International Immunopharmacology
56. Multi-Omics Characteristics of Ferroptosis Associated with Colon Adenocarcinoma Typing and Survival
    Xiao‐Qiong Chen, Ke Lian, Ziwei Chen, Xuan Zhang, Ting Li, Tao Wu, Tao Shen, Xinyi Cai, Xianshuo Cheng, Fu‐Hui Xiao et al. · 2024 · Frontiers in Bioscience-Landmark
57. Nanotechnology and Immunomodulators in Cancer
    Constantin D. Volovat, Simona Ruxandra Volovăț, Maricel Agop · 2022 · Springer eBooks
58. Integrative analysis indicates the prognostic value of circadian rhythm disruption in liver cancer: Potential for therapeutic targeting
    Ruiqi Wang, Wei Cui, Jiayi Cai, Yihao Sun · 2022 · Frontiers in Immunology
59. Non-cellular immunotherapies in pediatric central nervous system tumors
    Sarah Rumler · 2023 · Frontiers in Immunology
60. Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study
    Nahla E. El‐Ashmawy, Enas A. El-Zamarany, Eman Gouda Khedr, Hoda A. El‐Bahrawy, Ola A. El-Feky · 2018 · Clinical and Experimental Medicine
61. CD45 threads the needle of cytokine cancer immunotherapy
    Nils Wellhausen, Saar I. Gill · 2024 · Nature Immunology
62. Haploidentical hematopoietic cell transplantation as a platform for natural killer cell immunotherapy
    Rémy Duléry, Sara Piccinelli, Mohmad Shahnawaz Beg, Ji Eun Jang, Rizwan Romee · 2024 · American Journal of Hematology
63. Understanding and Overcoming Immunotherapy Resistance in Skin Cancer: Mechanisms and Strategies
    Shreya Singh Beniwal, Abhimanyu Chiraparambil Radhakrishnan, Ayanchetty Haripraba, Saif Syed, Gajawada Pragna, Ayush Dwivedi, Akash Singh Rawat, Daniela Castro Calderón, Martin Cevallos‐Cueva · 2025 · Aging and Cancer
64. Engineering Fusion Proteins for Nanomedicine-Based Cytokine Therapy
    Anne de Dreu, Koen de Bruin, Ayla M. Hokke, David P. Schrijver, Danyel N. H. Beelen, Lars M. Verhalle, Maria C. Clavijo Perez, Tom Anbergen, Iris Versteeg, Rianne J. F. Maas et al. · 2025 · Bioconjugate Chemistry
65. IL-18-armed oncolytic vaccinia virus remodels the suppressive microenvironment via macrophage and Treg modulation in lymphoma
    Hui Wu, Jiaqing Zhang, Li Xu, Yifan Xie, Lingli Pan, Xinyue Zhang, Yongming Xia, Fang Yang, Xiaozhen Kang, Xiangmin Tong et al. · 2026 · Cancer Immunology Immunotherapy
66. Inflammation and carcinogenesis: molecular targets and small-molecule intervention strategies
    Wan‐Jung Lu, Ritu Ojha, Mandeep Rana, Vinod Gautam, Jiun-Yi Li, Shao-An Wang · 2026 · Journal of Enzyme Inhibition and Medicinal Chemistry
67. Serum Levels of IL-21 and IL-22 in Breast Cancer Patients—A Preliminary Study
    Jacek Kabut, Aleksandra Mielczarek‐Palacz, Joanna Magdalena Gola, Elżbieta Chełmecka, Anita Gorzelak-Magiera, Patrycja Królewska‐Daszczyńska, Sebastian Stępień, Jakub Szymon Wnuk, Iwona Gisterek · 2025 · Current Issues in Molecular Biology
68. Investigation of Interleukin-27 in the Sera of Nonmelanoma Skin Cancer Patients
    Mehdi Ghahartars, Shiva Najafzadeh, Shabnam Abtahi, Mohammad Javad Fattahi, Abbas Ali Ghaderi · 2018 · Dermatology Research and Practice
69. Immunotherapy in Genitourinary Malignancy: Evolution in Revolution or Revolution in Evolution
    Kevin L. Lu, Kun‐Yuan Chiu, Chen‐Li Cheng · 2022 · Cancer treatment and research
70. Modern T cell technologies for immunotherapy of solid tumors
    Maria S. Kuznetsova, Hiroshi Shiku, Alexander Viktorovich Karaulov, Sergey Vitalievich Sennikov · 2023 · Medical Immunology (Russia)
71. A multipurpose brachytherapy catheter to enable intratumoral injection
    Justin C. Jagodinsky, Gabriella Medeiros, Hayley H. Raj, Amira Razuan, Alexis Locsin, Tirhas G. Dempsey, Beixiao Tang, Ishan Chakravarty, Paul A. Clark, Raghava N. Sriramaneni et al. · 2021 · Brachytherapy
72. Immunomodulatory, Antioxidant, Antiangiogenic, and Antiproliferative Effects of Rice Bran Arabinoxylan
    Soo Liang Ooi, Sok Cheon Pak, Peter S. Micalos · 2023 · Springer eBooks
73. Innate and adaptive immunity in cancer
    Aatman S. Doshi, Kirtika H. Asrani · 2021 · Elsevier eBooks
74. Pembrolizumab plus ipilimumab or pegylated interferon alfa-2b for patients with melanoma or renal cell carcinoma: take new drugs but keep the old?
    Matthew R. Zibelman, Elizabeth R. Plimack · 2019 · Annals of Translational Medicine
75. Roles of Annexin A1 Expression in Small Cell Lung Cancer
    Ágnes Paál, Dávid Dóra, Ákos Takács, Christopher J. Rivard, Shivaun Lueke Pickard, Fred R. Hirsch, Brigitta Roskó, Peter Kiraly, Péter Ferdinandy, Zoltán V. Varga et al. · 2025 · Cancers
76. An Immunomodulating Peptide with Potential to Promote Anticancer Immunity Without Compromising Immune Tolerance
    Michael Agrez, Christopher Chandler, Amanda L. Johnson, Marlena Sorensen, Kirstin Cho, Stephen Parker, Benjamin J. Blyth, Darryl G. Turner, Justyna Rzepecka, Gavin Knox et al. · 2025 · Biomedicines
77. Smart Biomaterials as Immunomodulators in Cancer Therapy
    Amit Sharma, Bhavin K Parekh, Vinay Patil, Renuka Jyothi S., Priya Priyadarshini Nayak, J Bethanney Janney, Gurjant Singh, Hasnaawei Al‐Shaker · 2025 · Immunology
78. Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers
    Jibran Ahmed, Geraldine O’Sullivan Coyne, Larry V Rubinstein, Sarah J Shin, Naoko Takebe, Ashley Bruns, Brooke Augustine, Jessica Mukherjee, Ning Ma, Kristin Fino et al. · 2025 · Journal for ImmunoTherapy of Cancer
79. Hydrogel-based delivery of cytokines in cancer immunotherapy: Latest evidence and therapeutic outcomes
    Hossein Khorramdelazad, Ali Pirsadeghi, Elias Amraei, Arash Amani, Mahdieh Abbasnia, Fatemeh Nematzade, Erfan Shahabinejad, Romina Naeinipour Mahabadi, Samin Ghanizadeh, Fateme Sadat Kouchakzade et al. · 2026 · Biomedicine & Pharmacotherapy
80. Regulatory effects of traditional Chinese medicine on the breast-cancer immune microenvironment
    Tingting Liu, Jingying Shang, Jiameng Wang, Lutuo Han, Mingyue Yang, Ruonan Li, Baoyi Ni, Jiakang Jiang · 2026 · Frontiers in Immunology
81. IL-6 drives chemoimmunotherapy resistance in NSCLC by reprogramming myeloid cells and impairing cytotoxic lymphocyte function
    Yaning Yang, Chengming Liu, Lu Yang, Sufei Zheng, Haiyan Xu, Shuyang Zhang, Linyan Tian, Nan Sun, Jie He, Yan Wang · 2026 · Cancer Letters
82. Cytokine production by blood cells and tumor samples and its coupling to microRNA expression in breast cancer patients
    Студеникина Анастасия Александровна, M. L. Perepechaeva, E. S. Mikhaylova, Вараксин Николай Анатольевич, А. I. Autenshlyus · 2023 · Medical Immunology (Russia)
83. The Therapeutic Potential of Targeting Tumor Microenvironment and Modulation of Immunotherapy in Gastrointestinal Cancer
    Saeideh Khorshid Sokhangouy, Hamid Jamialahmadi, Mahdieh Sadat Mortazavi Sani, Ghazaleh Khalili‐Tanha, Arian Karimi Rouzbahani, Golnaz Mahmoudvand, Zahra Goudarzi, Arshia Fakouri, Simin Farokhi, Seyed Mahdi Hassanian et al. · 2024 · Current Cancer Drug Targets
84. B-cell editing: An emerging alternative of precision oncotherapy
    Pritha Roy Choudhury, Mohona Chakravarti, Saptak Banerjee, Rathindranath Baral, Anamika Bose · 2024 · Advances in immunology
85. Based on the immune system: the role of the IL-2 family in pancreatic disease
    Yuqing Zhu, Zheng Lu, Zhuo Wang, Jiao Liu, Ke Ning · 2025 · Frontiers in Immunology
86. Novel therapeutic strategies for non‑small cell lung cancer: Combination therapies with immune checkpoint inhibitors (Review)
    Shengyao Ma, Ruixin Hu, Xiaobin Xue, Meihua Qu, Guoping Sun · 2025 · Oncology Letters
87. Innate lymphoid cells and gastrointestinal disease
    Ziyu Wang, Jun Wang · 2021 · Journal of genetics and genomics/Journal of Genetics and Genomics
88. Cancer and immunotherapy
    Atul Khajuria, Shilpa S Kushte · 2023 · Santosh University Journal of Health Sciences
89. Bypassing the cytokine sink: IL-2-independent IL-2 receptor signaling
    Tim Luetkens · 2023 · Molecular Therapy
90. Unveiling the link between inflammasomes and skin cutaneous melanoma: Insights into expression patterns and immunotherapy response prediction
    Yu Sheng, Jing Liu, Miao Zhang, Shuyun Zheng · 2023 · Mathematical Biosciences & Engineering
91. Revolutionizing Oral Cancer Treatment: Immunotherapeutic Approaches
    Md Moidul Islam, Sarjana Raikwar · 2024 · Current Cancer Therapy Reviews
92. Cytokines in Cancer Immunotherapy
    Raki Sudan · 2020 · Springer eBooks
93. Cancer Immunology and the Evolution of Immunotherapy
    Roza Nurieva, Margarita Divenko, Sang Kim · 2021 · Springer eBooks
94. Immune System in Action
    Bettzy Stephen, Joud Hajjar · 2021 · Advances in experimental medicine and biology
95. Genetic Polymorphisms and Molecular Mechanisms Mediating Oncolytic Potency of Reovirus Strains
    Adil Mohamed, Derek R. Clements, Prathyusha Konda, Shashi Ashok Gujar, Patrick W.K. Lee, James R. Smiley, Maya Shmulevitz · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
96. A meta-analysis of epitopes in prostate-specific antigens identifies opportunities and knowledge gaps
    Gabriele E. Foos, Nina Blazeska, Morten Nielsen, Hannah K. Carter, Zeynep Koşaloğlu‐Yalçın, Bjoern Peters, Alessandro Sette · 2023 · Human Immunology
97. Liquid–liquid phase separation for microencapsulation of native cytokine to enhance immune activation
    Zhenhua Hu, Cheng Li, Qiuling Chen, Tianqing Xin, Xiaoyan Wu · 2023 · Materials Advances
98. Cancer Immunotherapies: Navigating the Immune Landscape
    Rakesh Kumar, Joseph Finian Maleme, Shubham Kumar, Kalvatala Sudhakar, Darshan R. Telange, Oshin Maiti, Pratibha Sahoo, Alaa A. A. Aljabali, Vijay Mishra, Yachana Mishra · 2025 · Current Cancer Drug Targets
99. Co-encapsulation of norcantharidin prodrugs and lomitapide in nanoparticles to regulate CCL4 expression by inhibiting Wnt/β-catenin pathway for improved anti-tumor immunotherapy
    Feng Hua Zhao, Liming Gong, Ping Wang, Dong Chen, Shijie Cao, Feifei Yang, Manqing Tang, Yuanyuan Meng, Yuming Wang, Lin Miao et al. · 2025 · Journal of Nanobiotechnology
100. Toward a greener pharmaceutical industry using microalgae as a cell biofactory for the production of biologics
     Nesrine Gargouch, Charlotte Toustou, Patrice Lerouge, Muriel Bardor · 2025 · Elsevier eBooks